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Abstract
Objective
In this nationwide study we assessed the use and factors associated with future in vitro fertil-
ization (IVF) treatment after induced abortion.
Materials and methods
The study population was collected by means of record linkage between Finnish national
registers. All women who underwent induced abortion between 2000 and 2009 in Finland
were identified through the Register of Induced Abortions (n = 88 522). The study group con-
sisted of women who underwent induced abortion and subsequently had an IVF treatment
(n = 379); the comparison group were all women who had a spontaneous pregnancy and
delivery 12–24 months after the index abortion (n = 7434).
Demographic characteristics at the time of index abortion, and factors associated with
the abortion (gestational age at abortion, indication and method of abortion, complications
after abortion) were compared between the study groups. Logistic regression was used to
assess whether some of the demographic characteristics or abortion associated factors
increased the use of IVF treatment in the future.
Results
The proportion of women with IVF treatment after induced abortion in the whole cohort was
0.4%. Women needing IVF treatment were older, of a higher socioeconomic status, and had
fewer previous induced abortions and deliveries compared to women in the comparison
group. No statistically significant differences were observed in the gestational age (� 12
weeks or >12 weeks of gestation) at abortion, method or complications of abortion. In multi-
variable analysis higher age increased, and history of previous deliveries or one or two abor-
tions decreased the use of IVF.
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Conclusions
Infertility necessitating the use of IVF treatment after induced abortion is uncommon. The
factors associated with use of IVF after abortion are those generally recognized as risk fac-
tors of infertility. Abortion-related outcomes are not associated with an increased need of
future IVF-treatment.
Introduction
Concerns about induced abortion jeopardizing future fertility have prevailed, even though
studies from the 1980s and 1990s concluded that legal abortion has no adverse effects on future
fertility [1–3]. The possible mechanisms how abortion could affect the fertility are likely to
involve abortion affecting the fallopian tubes or endometrium due to infection, or mechanical
trauma leading to infertility and future IVF treatments. However, there are no studies proving
this theory.
Approximately half of women undergoing induced abortion have no previous births pre-
ceding abortion [4, 5] and the question of whether there are abortion-related factors, such as
gestational age at abortion, method and complications of abortion, which may affect future fer-
tility is important. The prevalence of infertility lasting for at least one year has been estimated
to be approximately 15% in high-income countries [6]. In Finland, the rate of in vitro fertiliza-
tion (IVF) treatment use among fertile aged women (15–49 years) was 7.5 per 1000 women in
2016, and altogether 6.5% of all children were born following assisted fertility treatments [5].
The procedure of induced abortion has changed dramatically during the past 20 years and
surgical method has been replaced by a medication method in a growing number of countries.
In Finland, the medication abortion with mifepristone and misoprostol was introduced in
2000 and the use of medication method has expanded since then: 97% of terminations were
performed medically in 2017 [5]. The same upward trend can be seen in other countries, such
as the United Kingdom and Norway [4, 7]. However, no studies on abortion and future fertil-
ity have been conducted since this change in abortion practice.
In the present study, we assessed the prevalence and the factors associated with future use
of in vitro fertilization (IVF) treatment after induced abortion, and whether there are some
abortion-related factors, such as gestational age at abortion, indication of abortion, method of
abortion, or complications after abortion, associated with the use of these treatments. We com-
pared women who suffered infertility treated by means of IVF after an abortion to women
who had a spontaneous pregnancy and delivery within 12–24 months after the index abortion.
Material and methods
In Finland, induced abortions are performed by healthcare professionals according to national
law and guidelines [8]. Abortion is regulated by the legislation and requires an indication [9].
Indications include age less than 17 years or above 40 years at conception, having delivered at
least four children, social circumstances, pregnancy being a risk for the woman’s life or health,
suspected or confirmed anomaly or illness of the fetus or mother’s and/or father’s incapability
to take care of the child, rape and incest or other reasons mentioned in the penal law. All abor-
tions are to be registered to the Finnish Register of Induced Abortions maintained by the Finn-
ish Institute of Health and Welfare [5]. The same institution maintains the Medical Birth
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Register, where all live births and stillbirths exceeding 22 gestational weeks or 500 grams in
fetal weight are registered since 1987.
IVF treatments are provided in specialized public and private clinics, and usually include
use of specific medications. Women below 40 years of age are entitled to low-cost IVF treat-
ment provided by the public health care. In private clinics couples have to pay for the treat-
ment. The medication prescriptions are reimbursed and filed in the Drug Reimbursement
Register maintained by the Social Insurance Institution. It also partly reimburses the costs of
treatments in private healthcare, including IVF treatments. These reimbursements are regis-
tered to the Procedure Reimbursement Register.
Furthermore, all Finnish hospitals provide information on diagnosis (International Classifi-
cation of Diseases, ICD-10) [10] and procedures (NOMESCO Classification of Surgical Proce-
dures) [11] of treatment episodes to the Hospital Discharge Register on all inpatient (all
hospitals) and outpatient treatment visits (public hospitals).
In this population-based register study, we identified all women undergoing induced abor-
tion between 2000 and 2009 (n = 88 522) by using the Finnish Register of Induced Abortions
(Fig 1). Information on these women was linked to the Drug Reimbursement Register, the
Procedures Reimbursement Register, the Hospital Discharge Register, and Medical Birth Reg-
ister in order to identify women, who subsequently underwent IVF treatment or had a sponta-
neous pregnancy and delivery 12–24 months after abortion with no infertility drugs,
procedures or diagnoses recorded into the registers. Women receiving IVF treatments were
identified by searching through registers special infertility drug codes, IVF procedures
(Table 1) and diagnoses indicating infertility. If a woman had a registered IVF procedure, or
had used combination of gonadotrophin releasing hormone agonist or antagonist and gonad-
otrophins, or had used gonadotrophin releasing hormone agonist or antagonist and had infer-
tility diagnoses, she was considered as being treated with IVF. Women who had used only
Fig 1. Flow chart detailing the study groups.
https://doi.org/10.1371/journal.pone.0225162.g001
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follicle stimulating hormone and had no IVF procedures were excluded as they could not be
verified as IVF treated.
The induced abortion preceding the IVF treatment or delivery was considered the index
abortion. Infertility treatments were identified until the end of 2010 and deliveries until end of
2009. Women who had deliveries between induced abortion and IVF treatment, women who
had infertility treatments prior to the index abortion during study period, and women who
had used only gonadotrophin releasing hormone agonist or antagonist and had diagnoses
indicating endometriosis, were excluded. In the medical literature, trying to conceive without
conception for at least one year is referred as infertility or subfertility [12], hence the women
who were treated with IVF within less than a year after the abortion (n = 34) were excluded. In
order to exclude possible unsuccessful induced abortions leading to continuing pregnancy and
delivery, women who delivered less than a year after the abortion (n = 1145) were also
excluded.
Women who met the inclusion criterion were divided into two groups: those who had their
first IVF procedure at least 12 months after the index induced abortion were chosen as the IVF
group (n = 379) and those who had no IVF treatment, but had spontaneous pregnancy and
delivery within 12–24 months after the index abortion, were chosen as the comparison group
(n = 7434) (Fig 1). By choosing women who deliver soon after the abortion we could eliminate
the possibility of subfertility, and could compare groups who did not have difficulties in getting
pregnant to those who had such problems. The background characteristics at the time of abor-
tion and the factors associated with the index abortion were compared between the two
groups. Furthermore, the use of IVF treatment in the future was evaluated according to differ-
ent background factors.
The data on background characteristics including age, marital status, occupation, type of
residence, as well as number of previous births, miscarriages and induced abortions were
retrieved from the Register of Induced Abortion. Socioeconomic status (SES) was defined
according to the stated occupation or the highest educational level reported to the Register of
Table 1. Infertility medication and procedure codes used in identification of IVF cases.
Group Code IVF case
Infertility medication ATC codes H01CA02 nafarelin
L02AE01 buserelin
H01CC01 ganirelix
H01CC02 cetrorelix
G03GA01 choriogonadotrophin
G03GA02 menotrophin
G03GA04 urofollitropin
G03GA05 follitropin alpha
G03GA06 follitropin beta
G03GA09 corifollitropin alpha
IVF procedure codes: TLW10 Fresh embryo transfer
TLW11 Transmyometrial embryo transfer
TLW12 Frozen embryo transfer
TLW14 Embryo transfer after ICSI
LBF11 Laparoscopy for assisted fertilization
LFB12 Hysteroscopy for assisted fertilization
LAA10 Percutaneous or transvaginal puncture and recovery of oocyte
LAA11 Laparoscopic recovery of oocyte
https://doi.org/10.1371/journal.pone.0225162.t001
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Induced Abortion. Coding was based on national standards published by Statistics Finland
[13–15]. The factors associated with abortion included gestational age at abortion determined
usually by ultrasonographic examination, indication and method of abortion, and complica-
tions after abortion, and were retrieved from Register of Induced Abortions and completed
with the data on complications obtained from Hospital Discharge Register. Methods of abor-
tion were divided to medication, surgical, and other (e.g. abortion by means of hysterotomy or
otherwise specified). Gestational age at abortion was divided to early (� 12 weeks) and late
(> 12 weeks) according to the Finnish legislation on induced abortions. Complications of the
abortion were defined as an infection, hemorrhage, incomplete abortion or surgical re-evacua-
tion of retained products of conception after abortion. In order to identify abortions with com-
plication(s), the diagnoses indicating infection, hemorrhage and incomplete abortion based on
ICD-10 and codes for surgical evacuations based on NOMESCO Classification of Surgical Pro-
cedures were searched through the data within 42 days after abortion.
The study was approved by the Ethics Committee of the Northern Ostrobothnia Hospital
District (no.28/2010). The Finnish Institute for Health and Welfare gave permission (THL/
659/5.05.00/2010) to use personal-level data from the national health registers. Personal identi-
fication numbers were removed and the data was fully anonymized before all analyses.
Statistical analyses
Statistical analyses were performed using PASW 23 for Windows (SPSS Inc., Chicago, IL,
USA). To assess the differences of the background characteristics and abortion-associated
background factors (gestational age at abortion, method of abortion, indication of abortion,
complications of abortion) between the study groups Chi-square or Fisher’s exact test were
used as appropriate for categorical variables and Mann-Whitney U-test for continuous vari-
ables. Bivariable logistic regression was used to assess whether potential covariates (i.e. the
background characteristics or the abortion associated background factors) increased the use of
IVF treatment compared with that in comparison women. Possible multicollinearity among
the potential covariates was examined by calculating the Variance Inflation Factor (VIF). Age
at the time of induced abortion, socioeconomic status, number of previous abortions and
number of previous deliveries were chosen as covariates in the final multivariable logistic
regression analysis, as these factors were found to be relevant confounders and also showed
association in bivariable analysis. The level of statistical significance was set at p< 0.05.
Results
Of the 88 522 women who underwent induced abortion, 379 (0.4%) received subsequent IVF
treatment. Women treated by means of IVF were older, of higher socioeconomic status and
had fewer previous induced abortions and deliveries compared with women in the comparison
group (Table 2). The median age at the time of IVF treatment was 32 years (IQR 28–37) and
the mean time between abortion and IVF treatment was 4.7 years (range 1.1–10.6). No signifi-
cant differences were observed between the IVF and comparison groups in the abortion-asso-
ciated factors: gestational age at abortion (� 12 weeks or> 12 weeks), method of abortion or
complications at abortion. The median of gestational age at the time of abortion was lower in
IVF group (p = 0.006) (Table 3).
In bivariable analysis the use of IVF treatment increased with age at the time of induced
abortion (Fig 2), and was highest among women aged 40 or more (OR 4.13, 95% CI 2.29–
7.44). Greater parity and lower socioeconomic status at the time of abortion were associated
with lower use of IVF treatment. History of previous induced abortion at the time of index
abortion also lowered the risk of using IVF treatment when compared to women with no such
Induced abortion and future fertility
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history. The association vanished for women with three or more abortions. Gestational age at
abortion, the method of abortion and complications at the time of abortion, such as surgical
re-evacuation, haemorrhage, incomplete abortion or infection, were not associated with the
future IVF treatment. When the indication for induced abortion was age above 40 years, the
use of IVF was increased.
Table 2. Demographic characteristics of the women at the time of induced abortion. Data are reported as number of women (%) unless stated otherwise.
Characteristics IVF group (n = 379) Comparison group (n = 7434) P
Age, years:
Median (IQR) 28 (23–33) 25 (20–30) < 0.001
� 19 44 (11.6) 1490 (20.0) < 0.001
20–24 70 (18.5) 2197 (29.6)
25–29 103 (27.2) 1768 (23.8)
30–34 95 (25.1) 1256 (16.9)
35–39 52 (13.7) 609 (8.2)
� 40 15 (4.0) 114 (1.5)
Marital status: 0.172
Married 75 (19.8) 1628 (21.9)
Cohabiting 73 (19.3) 1539 (20.7)
Single 200 (52.8) 3767 (50.7)
Divorced or widowed 30 (7.9) 498 (6.7)
Unknown 1 (0.3) 2 (0.0)
Socioeconomic status: < 0.001
Upper white-collar worker 67 (17.7) 603 (8.1)
Lower white-collar worker 110 (29.0) 1700 (22.9)
Blue-collar worker 45 (11.9) 1209 (16.3)
Students 87 (23.0) 1919 (25.8)
Other 17 (4.5) 690 (9.3)
Unknown 53 (14.0) 1313 (17.7)
Type of residence: 0.151
Urban 296 (78.1) 5418 (72.9)
Densely populated 39 (10.3) 986 (13.3)
Rural 44 (11.6) 1026 (13.8)
Unknown 0 (0.0) 4 (0.1)
Number of previous abortions: 0.001
0 295 (77.8) 5114 (68.8)
1–2 75 (19.8) 2139 (28.8)
� 3 9 (2.4) 180 (2.4)
Unknown 0 (0.0) 1 (0.0)
Number of previous deliveries: < 0.001
0 266 (70.2) 3718 (50.0)
1–2 92 (24.3) 3071 (41.3)
� 3 21 (5.5) 645 (8.7)
Number of previous miscarriages: 0.663
0 319 (84.2) 6204 (83.5)
1–2 55 (14.5) 1154 (15.5)
� 3 5 (1.3) 76 (1.0)
IQR = Inter-quartile range, IVF = In vitro fertilization.
https://doi.org/10.1371/journal.pone.0225162.t002
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In multivariable analysis after adjustments, higher age was still associated with the use of
IVF treatment. Women with previous deliveries or with a history of one or two induced abor-
tions had lower use of IVF. The association between socioeconomic status and IVF treatment
was no longer statistically significant (Fig 3). When the indication for termination was age of
40 or above, the use of IVF treatment was increased in the bivariable analysis, but this variable
was not included in the multivariable analysis to avoid multicollinearity.
Discussion
We find that the proportion of women using IVF treatment within 1 to 10 years after induced
abortion was low, 0.4%. Moreover, factors associated with induced abortion such as gestational
age at abortion, method of abortion and complications following abortion were not associated
with the use of IVF treatment later. Instead, the factors associated with IVF were those gener-
ally known to associate with infertility: advanced age and a lower number of previous deliver-
ies at the time of induced abortion. The number of previous abortions was lower in the IVF
group and a history of abortion was associated with lower use of IVF, which supports the con-
clusion that IVF was mainly due to other infertility factors and not related to the induced
abortion.
Table 3. Induced abortion-associated background factors. Data are number of women (%) unless stated otherwise.
Characteristics IVF group (n = 379) Comparison group (n = 7434) P-value
Gestational age at abortion (wk):
Median (IQR) 8 (7–11) 9 (7–11) 0.006
� 12 324 (85.5) 6217 (83.6) 0.339
> 12 55 (14.5) 1217 (16.4)
Method of abortion: 0.187
Medication 190 (50.1) 4046 (54.4)
Surgical 189 (49.9) 3386 (45.5)
Other 0 (0.0) 2 (0.0)
Indication for abortion: 0.198
Social 314 (82.8) 6231 (83.8)
Age < 17 y 8 (2.1) 205 (2.8)
Age� 40 y 5 (1.3) 32 (0.4)
� 4 children 3 (0.8) 83 (1.1)
Fetal indication 49 (12.9) 858 (11.5)
Other 0 (0.0) 25 (0.3)
Surgical re-evacuation after abortion: 0.808
Yes 37 (9.8) 698 (9.4)
No 342 (90.2) 6736 (90.6)
Haemorrhage after abortion: 0.568
Yes 31 (8.2) 672 (9.0)
No 348 (91.8) 6762 (91.0)
Incomplete abortion: 0.239
Yes 21 (5.5) 318 (4.3)
No 358 (94.5) 7116 (95.7)
Infection after abortion: 0.625
Yes 13 (3.4) 292 (3.9)
No 366 (96.6) 7142 (96.1)
IQR = Inter-quartile range, IVF = In vitro fertilization.
https://doi.org/10.1371/journal.pone.0225162.t003
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Fig 2. The association of characteristics, and induced abortion-associated background factors, with the future IVF
treatment (unadjusted odds ratios) (n = 7813). Note the logarithmic scale on the horizontal axis. TOP = Termination
of pregnancy.
https://doi.org/10.1371/journal.pone.0225162.g002
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This study is based on high-quality health registers. In a recent study, the coverage of the
Finnish Register of Induced Abortions was shown to be high, 97% of induced abortions were
reported in the register and over 90% of individual variables were exactly matched in clinical
and register data in a recent study [16]. Another study showed that identification of infertility
treatments based on treatment reimbursements is effective [17].
One of the limitations of our study is the fact that apart from IVF, other infertility treat-
ments such as induction of ovulation and intrauterine insemination could not be reliably iden-
tified by using these registers. Furthermore, we could not comprehensively differentiate
women who were treated with IVF because of male factor infertility or women with miscar-
riages after induced abortion because of lack of appropriate registration. However, as the
potential mechanism behind abortion-related infertility is the damage of the fallopian tubes,
endometrium, or mechanical trauma, lacking information of ovulation induction, intrauterine
insemination and male factor infertility will probably not affect the results. We followed deliv-
eries only until the end of 2009 and the use of IVF-treatments until 2010. However, the poten-
tial bias caused by this would overestimate the need of IVF after induced abortion.
Furthermore, medication abortion became first available in Finland in 2000, and the transition
to its dominant use occurred during the following 10 years (approx. 85% in 2009 [5]). There-
fore, to be able to assess the effects of surgical vs. medication abortion on the use of IVF-treat-
ment, a time period during which the use of the two means of induced abortion was roughly
similar was selected. Finally, we only held information on actual IVF treatments performed,
but not the need for such treatments. The need of IVF after abortion may be very low because
very few of the women undergoing induced abortion reached the age or place in their lives
Fig 3. The association of characteristics, and induced abortion-associated background factors, with the future IVF
treatment (adjusted odds ratios) (n = 7813). Note the logarithmic scale on the horizontal axis. TOP = Termination of
pregnancy.
https://doi.org/10.1371/journal.pone.0225162.g003
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when fertility was a concern. Moreover, the findings presented in this study are applicable in
countries where induced abortion is legal and infertility treatments are easily available.
By deciding to terminate the pregnancy, women may postpone their childbearing possibly
to an age when natural fertility is in decline. This is the most likely explanation for the future
use of IVF treatments after abortion. The mean monthly probability of conception declines
progressively after the age of 31 years [18]. The prevalence of one year of infertility increase to
more than 30% in the 35–44 -year age group compared to 6% for women less than 24 years-of-
age [18]. In our study the results reflect the same influence of age on fertility, when the age at
termination was 25 years or more the probability of being treated by means of IVF started to
increase and was highest when the age was above 40 years.
In accordance with our study, it has been shown that women who are treated with IVF after
induced abortion are more often nulliparous and have fewer previous abortions [19]. Thus,
even though the women seeking induced abortion are fertile, it seems that those women who
are later treated with IVF might in the first place present more subfertile population of
women.
Damage to the fallopian tubes after induced abortion due to infection or mechanical trauma
could theoretically lead to tubal infertility and IVF treatments. In our study, the abortion-
related complications, such as infection or surgical re-evacuation did not associate with IVF
treatment in the future. Two previous case-control studies have not found an association
between a positive history of induced abortion and tubal pathology [20, 21]. Furthermore,
even though the risks of incomplete abortion and surgical re-evacuation are higher after medi-
cation, compared to surgical induced abortion [22], the medication method of abortion was
not associated with the future IVF treatments in our study.
There are no studies evaluating the impact of medication induced abortion on future fertil-
ity. However, a study comparing the natural conception rates of women after medication
(n = 131) and surgical (n = 130) treatment of miscarriage has shown that the natural concep-
tion rates after both methods are 98% and the cumulative pregnancy rates are similar [23].
According to the present study prior medication abortion does not result in subsequent infer-
tility requiring IVF.
Based on the results of this large study, the overall future use of IVF treatment after abortion
is low. One explanation for this low use of IVF is the fact that the women having unplanned
pregnancies and undergoing induced abortion are generally highly fertile. The use of IVF is
associated with higher age and a lower overall number of deliveries and induced abortions at
the time of induced abortion, rather than abortion-associated factors. The factors found to be
associated with a future IVF are those generally recognized as risk factors of infertility. These
reassuring data are important when counseling women requesting an induced abortion.
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